Pneumococcal Conjugate Vaccine impact assessment in Bangladesh

The study examines the impact of the introduction of 10-valent Pneumococcal Conjugate Vaccine (PCV10) into Bangladesh’s national vaccine program. PCV10 is administered to children under 1 year-old; the scheduled ages of administration are at 6, 10, and 18 weeks. The study is conducted in ~770,000 po...

Descripción completa

Detalles Bibliográficos
Autores principales: Baqui, Abdullah H., McCollum, Eric D., Saha, Samir K., Roy, Arun K., Chowdhury, Nabidul H., Harrison, Meagan, Hanif, Abu Abdullah Mohammad, Simmons, Nicole, Mahmud, Arif, Begum, Nazma, Ahmed, Salahuddin, Khan, Ahad M., Ahmed, Zabed Bin, Islam, Maksuda, Mitra, Dipak, Quaiyum, Abdul, Chavez, Miguel A., Pervaiz, Farhan, Miele, Catherine H., Schuh, Holly B., Khanam, Rasheda, Checkley, William, Moulton, Lawrence H., Santosham, Mathuram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030398/
https://www.ncbi.nlm.nih.gov/pubmed/29984359
http://dx.doi.org/10.12688/gatesopenres.12805.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030398/
https://www.ncbi.nlm.nih.gov/pubmed/29984359
http://dx.doi.org/10.12688/gatesopenres.12805.1

Ejemplares similares